Document:

EX-10.18

 

Exhibit 10.18

REFINANCING ARRANGEMENTS AGREEMENT

          BIOSCRIP PHARMACY SERVICES, INC., a corporation organized under the laws of the State of Ohio
(“Pharmacy Services”), BIOSCRIP INFUSION SERVICES, INC., a corporation organized under the laws of
the State of California (“Infusion Services Inc”), BIOSCRIP PHARMACY (NY), INC., a corporation
organized under the laws of the State of New York (“Pharmacy (NY)”), BIOSCRIP PBM SERVICES, LLC, a
limited liability company organized under the laws of the State of Delaware (“PBM Services”),
BIOSCRIP PHARMACY, INC., a corporation organized under the laws of the State of Minnesota
(“Pharmacy”), NATURAL LIVING, INC., a corporation organized under the laws of the State of New York
(“Natural Living”) and BIOSCRIP INFUSION SERVICES, LLC, a limited liability company organized under
the laws of the State of Delaware (“Infusion Services LLC” and together with Pharmacy Services,
Infusion Services Inc, Pharmacy (NY), PBM Services, Pharmacy and Natural Living, each a “Provider”
and collectively, jointly and severally, the “Providers” and PBM Services in its capacity as
primary servicer hereunder, the “Primary Servicer”) and MIM FUNDING LLC, a limited liability
company organized under the laws of the State of Delaware (together with its corporate successors
and assigns, the “Purchaser”) agree as follows:

     The Providers and the Purchaser entered into a Receivables Purchase and Transfer Agreement,
dated as of November 1, 2000, as amended, restated, modified or supplemented from time to time in
accordance with its terms (the “RPTA”). Pursuant to the RPTA, the Providers agreed to sell or
contribute, and the Purchaser agreed to purchase or accept the contribution, on a continuing basis
all of the Providers receivables. Certain terms that are capitalized and used throughout this
Agreement are defined in the RPTA.

     The Purchaser and HFG HEALTHCO-4 LLC (“Assignee”) entered into an Assignment of Receivables
Purchase and Transfer Agreement as Collateral Security, dated as of November 1, 2000 pursuant to
which the Purchaser granted a security interest in and assigned and transferred to the Assignee all
of its rights, title and interest under the RPTA.

          In connection with the execution of an Amended and Restated Loan and Security Agreement among
the Providers[, the other borrowers party thereto] and Purchaser as borrowers and the Assignee as
the lender (the “Amended and Restated Loan Agreement”) on the date hereof the parties agree as
follows:

          1. Termination. Simultaneously with the execution of the Amended and Restated Loan
Agreement the RPTA shall be deemed to have terminated. The final Transfer Date shall be deemed to
have occurred on September 26, 2007 ( the “Purchase Termination Date”). On the Purchase
Termination Date (i) the obligations of the Providers to sell to the Purchaser, or contribute to
the capital of Purchaser, all Receivables as provided in Section 1.03 of the RPTA shall terminate
and (ii) the obligations of the Purchaser under the RPTA with respect to purchases and contributions of Receivables shall terminate including any obligation (x) to pay an
amount equal to the Purchase Price to the Primary Servicer for the benefit of the Providers, as set

 

 

forth in Section 1.03 of the RPTA and (y) to record on its books and records the capital
contribution of the Providers with respect to Receivables.

          2. Governing Law. This Agreement shall, in accordance with Section 5-1401 of the
General Obligations Law of the State of New York, be governed by the laws of the State of New York,
without regard to any conflicts of laws principles thereof that would call for the application of
the laws of any other jurisdiction.

 

 

     IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their respective
officers thereunto duly authorized, as of                                          ___, 2007.

	 	 	 	 	 
	PROVIDERS: 	BIOSCRIP PBM SERVICES, LLC (as successor to

MIM Health Plans, Inc.)

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	BIOSCRIP PHARMACY SERVICES, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	BIOSCRIP INFUSION SERVICES, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	BIOSCRIP PHARMACY (NY), INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	BIOSCRIP PHARMACY, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 

 

 

	 	 	 	 	 

	 	 	 	 	 
	 	NATURAL LIVING, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	BIOSCRIP INFUSION SERVICES, LLC

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	PURCHASER: 	MIM FUNDING LLC

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	PRIMARY SERVICER: 	BIOSCRIP PBM SERVICES, LLC (as successor to 

MIM Health Plans, Inc.)

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

CONSENTED TO:

	 	 	 	 	 
	BIOSCRIP, INC. (f/ka/ MIM CORPORATION)

 	 	 
	By:  	 	 
	 	Name:  	 	 	 
	 	Title:  	 	 	 
	 
	HFG HEALTHCO-4 LLC

 	 	 
	By:  	HFG Healthco-4, Inc., a member
 	 	 
	 	 	 	 
	 	 	 	 
	 
	 	 	 
	By:  	 	 	 
	 	Name:  	 	 	 
	 	Title:exv10w73

 

EXHIBIT 10-73

LTIP Amendment

Change in FMV Calculation

          WHEREAS, on April 27, 2006, the shareholders of this Company approved the DTE Energy Company 2006
Long-Term Incentive Plan (“LTIP”); and

          WHEREAS, Article 14.01 of the LTIP gives this Board authority to amend the LTIP when the
amendment is non-material; and

          WHEREAS, Article 2.13 of the LTIP defines “Fair Market Value” as follows:

Fair Market Value means, on the specified date, the average
of the highest and lowest sales prices of Common Stock
during normal business hours on the New York Stock
Exchange, as reported by a source selected by the Committee.
If, on the specified date, no share of Common Stock is traded,
then Fair Market Value is determined as of the next preceding
day that Common Stock was traded; and

          WHEREAS, the Organization and Compensation Committee of this Company has recommended to this
Board that the definition of “Fair Market Value” be amended as follows:

Fair Market Value means, on the specified date, the closing
price of Common Stock on the New York Stock Exchange,
as reported by a source selected by the Committee. If on
the specified date, no share of Common Stock is traded, then
Fair Market Value is determined as of the next preceding
day that Common Stock was traded; and

          WHEREAS, under the Corporate Governance Standards of the New York Stock Exchange Listed
Company Manual, this amendment to the LTIP would not be considered a material change that requires
shareholder approval.

          NOW, THEREFORE, BE IT

          RESOLVED, that Article 2.13 of the LTIP be, and it hereby is, amended, effectively
immediately, to define “Fair Market Value” as follows:

Fair Market Value means, on the specified date, the closing
price of Common Stock on the New York Stock Exchange,
as reported by a source selected by the Committee. If on
the specified date, no share of Common Stock is traded, then
Fair Market Value is determined as of the next preceding
day that Common Stock was traded; and

DTE Energy Company

Meeting of the Board of Directors

February 8, 2007

 

 

          RESOLVED, that the Chairman and Chief Executive Officer, the President and
the Vice President — Human Resources (“Named Officers”) of this Company be, and
they hereby are, authorized to execute and deliver all such documents that may be
necessary or advisable to carry into effect the purpose and intent of these
resolutions, and such Named Officers are further authorized to perform any and all
such acts as such officers deem appropriate to carry into effect the purpose and
intent of these resolutions.

DTE Energy Company

Meeting of the Board of Directors

February 8, 2007exv10w74

 

Exhibit 10-74

LTIP Amendment

Permit Delegation of Authority to President

          WHEREAS, on April 27, 2006, the shareholders of this Company approved the DTE Energy Company
2006 Long-Term Incentive Plan (“LTIP”); and

          WHEREAS, Article 14.01 of the LTIP gives this Board authority to amend the LTIP when the
amendment is non-material; and

          WHEREAS, the Organization and Compensation Committee of this Board has recommended that
Article 3.03 be amended to include a provision that the Committee may delegate to the President the
ability to make LTIP grants and awards to individuals not subject to the reporting and other
provisions of Section 16 of the Securities Exchange Act (Act); and

          WHEREAS, under the Corporate Governance Standards of the New York Stock Exchange Listed
Company Manual, this amendment to the LTIP would not be considered a material change that requires
shareholder approval.

          NOW, THEREFORE, BE IT

          RESOLVED, that Article 3.03 of the LTIP be, and it hereby is, amended, effectively
immediately, to read as follows:

3.03. Delegation

The Committee, in its discretion, may delegate to the Chief Executive Officer or
the President of the Company all or part of the Committee’s authority and duties
with respect to grants and awards to individuals who are not subject to the
reporting and other provisions of Section 16 of the Exchange Act. The Committee may
revoke or amend the terms of a delegation at any time. However, any revocation or
amendment of a delegation does not invalidate any prior actions of the Committee’s
delegate or delegates that were consistent with the terms of the Plan.

          RESOLVED, that the Chairman and Chief Executive Officer, the President and the Vice
President — Human Resources (“Named Officers”) of this Company be, and they hereby are,
authorized to execute and deliver all such documents that may be necessary or advisable to
carry into effect the purpose and intent of these resolutions, and such Named Officers are
further authorized to perform any and all such acts as such officers deem appropriate to
carry into effect the purpose and intent of these resolutions.

DTE Energy Company

Meeting of the Board of Directors

March 8, 2007

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}]]